145 related articles for article (PubMed ID: 31114500)
1. Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma.
Bilal F; Montfort A; Gilhodes J; Garcia V; Riond J; Carpentier S; Filleron T; Colacios C; Levade T; Daher A; Meyer N; Andrieu-Abadie N; Ségui B
Front Pharmacol; 2019; 10():443. PubMed ID: 31114500
[TBL] [Abstract][Full Text] [Related]
2. Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.
Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Hama K; Tanikawa T; Oka S; Saeki T; Kumasaka T; Koizumi T; Arai S; Wada I; Yokoyama K; Sugiura T; Yamashita A
J Biol Chem; 2018 Nov; 293(45):17505-17522. PubMed ID: 30242129
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
4. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
[TBL] [Abstract][Full Text] [Related]
5. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
[TBL] [Abstract][Full Text] [Related]
6. Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry.
Chen Y; Yurek DA; Yu L; Wang H; Ehsani ME; Qian YW; Konrad RJ; Jiang XC; Kuo MS; Cao G; Wang J
Anal Biochem; 2013 Jul; 438(1):61-6. PubMed ID: 23535273
[TBL] [Abstract][Full Text] [Related]
7. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
[TBL] [Abstract][Full Text] [Related]
9. [Expression of sphingomyelin synthase 1 (SGMS1) gene varies in human lung and oesophagus cancer].
Rozhkova AV; Zinovyeva MV; Sass AV; Zborovskaya IB; Limborska SA; Dergunova LV
Mol Biol (Mosk); 2014; 48(3):395-402. PubMed ID: 25831888
[TBL] [Abstract][Full Text] [Related]
10. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
[TBL] [Abstract][Full Text] [Related]
11. Subcellular targeting domains of sphingomyelin synthase 1 and 2.
Yeang C; Ding T; Chirico WJ; Jiang XC
Nutr Metab (Lond); 2011 Dec; 8():89. PubMed ID: 22168400
[TBL] [Abstract][Full Text] [Related]
12. Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.
Deevska GM; Dotson PP; Karakashian AA; Isaac G; Wrona M; Kelly SB; Merrill AH; Nikolova-Karakashian MN
J Biol Chem; 2017 Mar; 292(12):5110-5122. PubMed ID: 28087695
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-linked changes in the biosynthesis and turnover of sphingomyelins in rat male germ cells: Genes involved and effects of testosterone.
Santiago Valtierra FX; Aveldaño MI; Oresti GM
J Biol Chem; 2023 Apr; 299(4):103058. PubMed ID: 36841478
[TBL] [Abstract][Full Text] [Related]
14. Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage.
Separovic D; Semaan L; Tarca AL; Awad Maitah MY; Hanada K; Bielawski J; Villani M; Luberto C
Exp Cell Res; 2008 May; 314(8):1860-8. PubMed ID: 18374917
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.
Lu MH; Takemoto M; Watanabe K; Luo H; Nishimura M; Yano M; Tomimoto H; Okazaki T; Oike Y; Song WJ
J Physiol; 2012 Aug; 590(16):4029-44. PubMed ID: 22641779
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in cellular ceramide homeostasis.
Hussain MM; Jin W; Jiang XC
Nutr Metab (Lond); 2012 Jul; 9(1):71. PubMed ID: 22849442
[TBL] [Abstract][Full Text] [Related]
17. A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate.
Zama K; Mitsutake S; Watanabe K; Okazaki T; Igarashi Y
Chem Phys Lipids; 2012 Oct; 165(7):760-8. PubMed ID: 23063490
[TBL] [Abstract][Full Text] [Related]
18. The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA.
Fernández-García P; Rosselló CA; Rodríguez-Lorca R; Beteta-Göbel R; Fernández-Díaz J; Lladó V; Busquets X; Escribá PV
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30646599
[No Abstract] [Full Text] [Related]
19. Cryo-EM structure of human sphingomyelin synthase and its mechanistic implications for sphingomyelin synthesis.
Hu K; Zhang Q; Chen Y; Yang J; Xia Y; Rao B; Li S; Shen Y; Cao M; Lu H; Qin A; Jiang XC; Yao D; Zhao J; Zhou L; Cao Y
Nat Struct Mol Biol; 2024 Feb; ():. PubMed ID: 38388831
[TBL] [Abstract][Full Text] [Related]
20. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
